New drug combo shows promise for untreated CLL patients
Disease control
Ongoing
This early-phase study tested a combination of two drugs, daratumumab and ibrutinib, in 15 people with untreated chronic lymphocytic leukemia (CLL) who needed treatment. The goal was to see how safe the combination is and how well it works at controlling the disease. Participants…
Phase: PHASE1 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated May 11, 2026 20:49 UTC